NEW YORK (GenomeWeb) – Within a large pharmacogenetic study ongoing at several Indiana institutions, researchers are aiming to tackle the issues that have kept personalized medicine approaches from reaching disadvantaged communities.

Earlier this month, Eskenazi Health, the Indiana Institute for Personalized Medicine (IIPM), the Indiana University School of Medicine, and the Regenstrief Institute announced the launch of a 6,000-patient prospective trial to study the impact of preemptive pharmacogenetic testing in a community healthcare setting.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

Researchers link genetic links between education and smoking and longevity.

In PNAS this week: influence of gene environment interactions on polygenic traits, epigenetic features affecting fruit fly foraging, and more.